Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras

Virology Journal

Volumn 8, Issue , 2011, Pages

  Tang, Yunlian ^a   He, Rongfang ^a   Zhang, Yang ^a   Liu, Fang ^a   Cheng, Ailan ^a   Wu, Yimou ^a   Gan, Runliang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; CD79A ANTIGEN; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CELL DIFFERENTIATION; EPSTEIN BARR VIRUS ASSOCIATED LYMPHOMA; EPSTEIN BARR VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNODIFFUSION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PERIPHERAL LYMPHOCYTE; SCID MOUSE; ANIMAL; DISEASE MODEL; EPSTEIN BARR VIRUS; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE; MALE; MOUSE MUTANT; VIROLOGY;

ANIMALIA; HUMAN HERPESVIRUS 4; MUS;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; LYMPHOCYTES; LYMPHOMA, B-CELL; MALE; MICE; MICE, SCID;

EID: 79955695042     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-213     Document Type: Article

References (20)

1. EBV-associated lymphoproliferative disorders: classification and treatment. A Carbone A Gloghini G Dotti, Oncologist 2008 13 5 577 85 10.1634/theoncologist.2008-0036 18515742 (Pubitemid 351872874)
2. Progress and problems in understanding and managing primary Epstein-Barr virus infections. OA Odumade KA Hogquist HH Balfour Jr, Clin Microbiol Rev 2011 24 1 193 209 10.1128/CMR.00044-10 21233512
3. Viral origins of human cancer. E Boccardo LL Villa, Curr Med Chem 2007 14 24 2526 39 10.2174/092986707782023316 17979705 (Pubitemid 350018465)
4. The prevalence of Epstein-Barr virus infection in different types and sites of lymphomas. Y Zhang J Peng Y Tang J He J Peng Q Zhao R He X Xie X Peng R Gan, Jpn J Infect Dis 2010 6 2 132 35
5. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). J Gao X Luo K Tang X Li G Li, J Virol Methods 2006 136 1-2 193 9 10.1016/j.jviromet.2006.05.013 16806502 (Pubitemid 44051593)
6. The prevalence and prevention of nasopharyngeal carcinoma in China. SM Cao MJ Simons CN Qian, Chin J Cancer 2011 30 2 114 119 21272443
7. Humanized SCID mouse models for biomedical research. T Pearson DL Greiner LD Shultz, Curr Top Microbiol Immunol 2008 324 25 51 10.1007/978-3-540-75647-7- 2 18481451
8. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. T Strowig O Chijioke P Carrega F Arrey S Meixlsperger PC Rämer G Ferlazzo C Münz, Blood 2010 116 20 4158 67 10.1182/blood-2010-02-270678 20671122
9. The management of posttransplant lymphoproliferative disorder. NV Frey DE Tsai, Med Oncol 2007 24 2 125 36 10.1007/BF02698031 17848735 (Pubitemid 350135963)
10. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse. R Gan Z Yin T Liu L Wang Y Tang Y Song, Cancer Sci 2003 94 9 796 801 10.1111/j.1349-7006.2003.tb01521.x 12967478 (Pubitemid 37258778)
11. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. LD Shultz Y Saito Y Najima S Tanaka T Ochi M Tomizawa T Doi A Sone N Suzuki H Fujiwara M Yasukawa F Ishikawa, Proc Natl Acad Sci USA 2010 107 29 13022 7 10.1073/pnas.1000475107 20615947
12. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. K Sebelin-Wulf TD Nguyen S Oertel M Papp-Vary RU Trappe A Schulzki A Pezzutto H Riess M Subklewe, Transpl Immunol 2007 17 3 203 10 10.1016/j.trim.2006.10.006 17331848
13. Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders. H Khedmat S Alavian S Taheri, Ann Transplant 2010 15 2 40 4 20657518
14. AIDS-related lymphomas: from pathogenesis to pathology. A Carbone A Gloghini, Br J Haematol 2005 130 5 662 70 10.1111/j.1365-2141.2005.05613.x 16115121 (Pubitemid 43906640)
15. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. D Capello M Martini A Gloghini M Cerri S Rasi C Deambrogi M Spina U Tirelli LM Larocca A Carbone G Gaidano, Haematologica 2008 93 8 1178 85 10.3324/haematol.12705 18556404
16. Immunosurveillance, immunodeficiency and lymphoproliferations. SH Oertel H Riess, Recent Results Cancer Res 2002 159 1 8 10.1007/978-3-642-56352-2-1 11785833
17. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice. F Ye H Chen Z Liang W Lu Q Cheng X Xie, Eur J Gynaecol Oncol 2006 27 6 566 72 17290584 (Pubitemid 46166251)
18. Antigen-specific antibody production of human B cells in NOG mice reconstituted with the human immune system. R Ito M Shiina Y Saito Y Tokuda Y Kametani S Habu, Curr Top Microbiol Immunol 2008 324 95 107 10.1007/978-3-540- 75647-7-6 18481455
19. Human T-cell responses to oral streptococci in human PBMC-NOD/SCID mice. MA Salam R Nakao H Yonezawa H Watanabe H Senpuku, Oral Microbiol Immunol 2006 21 3 169 76 10.1111/j.1399-302X.2006.00272.x 16626374
20. Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras. J Zhang R Sun Z Tian, Clin Vaccine Immunol 2007 14 1 60 4 10.1128/CVI.00244-06 17079435